Magenta Therapeutics to Present at the Oppenheimer 31st Annual Healthcare Conference

Rhea-AI Summary

Magenta Therapeutics (NASDAQ: MGTA) will present at the Oppenheimer 31st Annual Healthcare Conference on March 18, 2021, at 10:00 a.m. ET. The event will be held virtually, and a live webcast can be accessed through the Magenta Therapeutics website, with a replay available for 90 days afterward.

Magenta is focused on developing novel therapies to harness the curative potential of stem cell transplants for patients with blood cancers, genetic disorders, and autoimmune diseases. Based in Cambridge, Mass, the company combines expertise in stem cell biology with regulatory proficiency.

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company is scheduled to present at the Oppenheimer 31^st Annual Healthcare Conference, to be held virtually, on Thursday, March 18^th, 2021, at 10:00 a.m. ET.

A live webcast of the presentation can be accessed on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations. The webcast replay will be available for 90 days following the event.

About Magenta Therapeutics

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210309005157/en/

FAQ

When is Magenta Therapeutics' presentation at the Oppenheimer 31st Annual Healthcare Conference?

Magenta Therapeutics will present on March 18, 2021, at 10:00 a.m. ET.

How can I access the webcast for Magenta Therapeutics' presentation?

The live webcast can be accessed on the Magenta Therapeutics website.

How long will the webcast replay of Magenta Therapeutics' presentation be available?

The webcast replay will be available for 90 days after the event.

What is Magenta Therapeutics' focus in biotechnology?

Magenta Therapeutics focuses on developing therapies to utilize the curative power of stem cell transplants.

Where is Magenta Therapeutics located?

Magenta Therapeutics is based in Cambridge, Massachusetts.